Inhibitors of Mitochondrial Fission As a Therapeutic Strategy for Diseases with Oxidative Stress and Mitochondrial Dysfunction

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2014 Jan 14

PMID 24413616

Citations 72

Authors

P Hemachandra Reddy

Affiliations

Soon will be listed here.

Abstract

Mitochondria are essential cytoplasmic organelles, critical for cell survival and death. Recent mitochondrial research revealed that mitochondrial dynamics-the balance of fission and fusion in normal mitochondrial dynamics--is an important cellular mechanism in eukaryotic cell and is involved in the maintenance of mitochondrial morphology, structure, number, distribution, and function. Research into mitochondria and cell function has revealed that mitochondrial dynamics is impaired in a large number of aging and neurodegenerative diseases, and in several inherited mitochondrial diseases, and that this impairment involves excessive mitochondrial fission, resulting in mitochondrial structural changes and dysfunction, and cell damage. Attempts have been made to develop molecules to reduce mitochondrial fission while maintaining normal mitochondrial fusion and function in those diseases that involve excessive mitochondrial fission. This review article discusses mechanisms of mitochondrial fission in normal and diseased states of mammalian cells and discusses research aimed at developing therapies, such as Mdivi, Dynasore and P110, to prevent or to inhibit excessive mitochondrial fission.

Citing Articles

Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer's Disease.

Ahlawat A, Walia V, Garg M Acta Neurol Belg. 2025; .

PMID: 39762668 DOI: 10.1007/s13760-024-02706-7.

The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.

Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D Biomolecules. 2024; 14(11).

PMID: 39595570 PMC: 11591570. DOI: 10.3390/biom14111393.

Disruption of Mitochondrial Quality Control in Inherited Metabolic Disorders.

Marcuzzo M, de Andrade Silveira J, Streck E, Vockley J, Leipnitz G Mol Neurobiol. 2024; .

PMID: 39251562 DOI: 10.1007/s12035-024-04467-z.

Vitamin D Alleviates Heavy Metal-Induced Cytotoxic Effects on Human Bone Osteoblasts Via the Induction of Bioenergetic Disruption, Oxidative Stress, and Apoptosis.

Elmorsy E, Al-Ghafari A, Al Doghaither H, Alrowaili M, Khired Z, Toraih E Biol Trace Elem Res. 2024; .

PMID: 39235540 DOI: 10.1007/s12011-024-04337-8.

Bacteria-organelle communication in physiology and disease.

Lee Y, Senturk M, Guan Y, Wang M J Cell Biol. 2024; 223(7).

PMID: 38748249 PMC: 11096858. DOI: 10.1083/jcb.202310134.

References

Xie N, Wang C, Lian Y, Zhang H, Wu C, Zhang Q . A selective inhibitor of Drp1, mdivi-1, protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neurosci Lett. 2013; 545:64-8. DOI: 10.1016/j.neulet.2013.04.026. View

Wang X, Yan M, Fujioka H, Liu J, Wilson-Delfosse A, Chen S . LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet. 2012; 21(9):1931-44. PMC: 3315202. DOI: 10.1093/hmg/dds003. View

Barsoum M, Yuan H, Gerencser A, Liot G, Kushnareva Y, Graber S . Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006; 25(16):3900-11. PMC: 1553198. DOI: 10.1038/sj.emboj.7601253. View

Quintanilla R, Matthews-Roberson T, Dolan P, Johnson G . Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J Biol Chem. 2009; 284(28):18754-66. PMC: 2707209. DOI: 10.1074/jbc.M808908200. View

Kalman B, Leist T . A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med. 2003; 3(3):147-58. DOI: 10.1385/NMM:3:3:147. View

Cassidy-Stone A, Chipuk J, Ingerman E, Song C, Yoo C, Kuwana T . Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell. 2008; 14(2):193-204. PMC: 2267902. DOI: 10.1016/j.devcel.2007.11.019. View

Silva D, Selfridge J, Lu J, E L, Roy N, Hutfles L . Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet. 2013; 22(19):3931-46. PMC: 3888119. DOI: 10.1093/hmg/ddt247. View

Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y . Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med. 2011; 17(3):377-82. PMC: 3051025. DOI: 10.1038/nm.2313. View

Gao B, Bataller R . Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141(5):1572-85. PMC: 3214974. DOI: 10.1053/j.gastro.2011.09.002. View

10.

Haider L, Fischer M, Frischer J, Bauer J, Hoftberger R, Botond G . Oxidative damage in multiple sclerosis lesions. Brain. 2011; 134(Pt 7):1914-24. PMC: 3122372. DOI: 10.1093/brain/awr128. View

11.

Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T . Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006; 10(6):839-50. DOI: 10.1016/j.devcel.2006.04.002. View

12.

Reddy P, Tripathi R, Troung Q, Tirumala K, Reddy T, Anekonda V . Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta. 2011; 1822(5):639-49. PMC: 3272314. DOI: 10.1016/j.bbadis.2011.10.011. View

13.

van Horssen J, Witte M, Schreibelt G, de Vries H . Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta. 2010; 1812(2):141-50. DOI: 10.1016/j.bbadis.2010.06.011. View

14.

Rambold A, Kostelecky B, Elia N, Lippincott-Schwartz J . Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci U S A. 2011; 108(25):10190-5. PMC: 3121813. DOI: 10.1073/pnas.1107402108. View

15.

Haun F, Nakamura T, Shiu A, Cho D, Tsunemi T, Holland E . S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease. Antioxid Redox Signal. 2013; 19(11):1173-84. PMC: 3785802. DOI: 10.1089/ars.2012.4928. View

16.

Tang W, Wu W, Qiu H, Bo H, Huang S . Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. J Nephrol. 2013; 26(6):1073-82. DOI: 10.5301/jn.5000268. View

17.

Schulz K, Eckert A, Rhein V, Mai S, Haase W, Reichert A . A new link to mitochondrial impairment in tauopathies. Mol Neurobiol. 2012; 46(1):205-16. DOI: 10.1007/s12035-012-8308-3. View

18.

Reddy P . Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med. 2008; 10(4):291-315. PMC: 3235551. DOI: 10.1007/s12017-008-8044-z. View

19.

Shirendeb U, Calkins M, Manczak M, Anekonda V, Dufour B, McBride J . Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Hum Mol Genet. 2011; 21(2):406-20. PMC: 3276281. DOI: 10.1093/hmg/ddr475. View

20.

Kim J, Moody J, Edgerly C, Bordiuk O, Cormier K, Smith K . Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet. 2010; 19(20):3919-35. PMC: 2947400. DOI: 10.1093/hmg/ddq306. View